In addition, the ST14 positive expression rates in borderline ovarian tumors and benign tumors were 83.3% (10/12) and 76.9% (10/13), which were significantly higher than those in normal ovarian epithelial tissues (P = 0.002, 0.007; Fig. 6A; Table 2). The gene discussed is ST14; the disease is benign neoplasm.